tiprankstipranks
Editas Medicine price target lowered to $4 from $5 at RBC Capital
PremiumThe FlyEditas Medicine price target lowered to $4 from $5 at RBC Capital
9d ago
Editas Medicine downgraded to Neutral from Buy at Chardan
Premium
The Fly
Editas Medicine downgraded to Neutral from Buy at Chardan
9d ago
Editas Medicine price target lowered to $8 from $10 at Baird
Premium
The Fly
Editas Medicine price target lowered to $8 from $10 at Baird
9d ago
Editas to reduce workforce by 65%, announces departure of CMO Baisong Mei
PremiumThe FlyEditas to reduce workforce by 65%, announces departure of CMO Baisong Mei
9d ago
Editas Medicine downgraded to Equal Weight from Overweight at Wells Fargo
Premium
The Fly
Editas Medicine downgraded to Equal Weight from Overweight at Wells Fargo
11d ago
Editas Medicine Updates RUBY Trial with Promising Results
Premium
Company Announcements
Editas Medicine Updates RUBY Trial with Promising Results
12d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1M ago
Editas upgraded at Evercore ISI on value of reni-cel, CRISPR platform
Premium
The Fly
Editas upgraded at Evercore ISI on value of reni-cel, CRISPR platform
2M ago
Editas Medicine upgraded to Outperform from In Line at Evercore ISI
Premium
The Fly
Editas Medicine upgraded to Outperform from In Line at Evercore ISI
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100